EnviroGold Global Limited ("EnviroGold," or the "Company"), a clean technology company reprocessing mine waste to produce precious and critical metals, unlocking significant value from mine waste and ...

In the ever-evolving digital landscape, the integration of Artificial Intelligence (AI) into patent lifecycle management is transforming the way intellectual property (IP) is handled, enhancing the ...

Recent USPTO guidance on subject-matter eligibility: In an effort to improve and standardize the examination of patent applications ... A modified flowchart that combines the two flowcharts ...

Opinion: Sterne Kessler’s Dohm Chankong and Richard Coller tell the medical device industry to look back and learn from ...

In this article, I switch the focus to exploring how the patent office great again (POGA) movement should prioritize ...

Starting May 13, the U.S. Patent and Trademark Office (USPTO) will accelerate the time between issue notification and the issue date of a patent.

The Trade-Adverse Trade Adviser: Once sidelined, President Trump’s counselor Peter Navarro has returned to Washington and quickly upended the global trading system.

"There has been a lot of interest in the filing of our patent application," a Baidu spokesperson said when asked how soon the company could turn the patent into a product. "Currently, it is still ...

The Patent Trial and Appeal Board is within the U.S. Patent and Trademark Office. Congressional supporters say the process has evolved into a “forum where patent claims are consistently ...

Visit SPARCRequest and select 'Funding Opportunities' on the left hand navigation menu. Choose a funding opportunity from the drop down menu (e.g. "Clinical and Translational Science Research Program" ...

There may be other contributing factors, notably the lengthy patent application process, that isn’t inherently moatworthy. In Australia, the process from application to grant can take two to ...

The FDA has approved Amgen and Allergan’s biosimilar of Roche’s Herceptin, just in time for the breast cancer blockbuster’s patent expiry. Herceptin’s main US patent expires this month ...